Scientists from the Universidad Católica San Antonio de Murcia and the Instituto de Investigación Sanitaria (Health Research Institute) of the Fundación Jiménez Díaz have found a new therapeutic target capable of improving pancreatic cancer treatments by inhibiting the growth of tumour cells and increasing their sensitivity to standard chemotherapy
UCAM and Fundación Jiménez Díaz develop a project led by Dr. Óscar Aguilera that provides important results regarding the use of Vitamin C in the treatment of tumours resistant to chemotherapy.
The processing of personal data responsible entity is SAN ANTONIO UNIVERSITY FOUNDATION (Fundación Universitaria San Antonio). Your personal data, including your mobile phone number, will be processed for the purposes of managing information and guidance activities, responding to your enquiries, and sending promotional communications and services related to the Institution through the University’s communication channels, including WhatsApp, email, and telephone.
The legal basis for this processing is your consent, which you may withdraw at any time by sending an email to the University Secretariat. Your data will be retained indefinitely until you request its cancellation. Further information about our Privacy Policy is available at www.ucam.edu.
You may contact the Data Protection Officer at dpd@ucam.edu
You have the right to access your data, rectify it, request its deletion, and exercise any other rights established under the LOPD and EU Regulation 2016/679 by contacting the University Secretariat, either in person or in writing, with proof of identity, at secretaria@ucam.edu.
